RESMED INC·4

Feb 6, 11:05 AM ET

Rider Michael J 4

4 · RESMED INC · Filed Feb 6, 2026

Research Summary

AI-generated summary of this filing

Updated

ResMed (RMD) Global GC Michael J. Rider Sells 50 Shares

What Happened
Michael J. Rider, Global General Counsel of ResMed Inc. (RMD), sold 50 shares in an open-market/private sale on February 4, 2026 at $260.00 per share, for proceeds of $13,000. This was a sale (not a purchase or option exercise), which is often a routine disposition by insiders.

Key Details

  • Transaction date and price: 2026-02-04 — 50 shares at $260.00 per share.
  • Total value: $13,000.
  • Transaction type: Reported as an open market or private sale (code S).
  • Footnote: Transaction was conducted under a Rule 10b5-1 trading plan adopted February 28, 2025.
  • Shares owned after transaction: Not disclosed in this filing.
  • Filing date: Form filed 2026-02-06; filing appears timely based on the reported transaction date.

Context
Sales executed under pre-established 10b5-1 plans are scheduled trades and are generally given less interpretive weight regarding the insider’s view of company prospects. The trade size here is modest (~$13k), so it’s a small, routine insider sale rather than a large directional move.

Insider Transaction Report

Form 4
Period: 2026-02-04
Rider Michael J
Global General Counsel
Transactions
  • Sale

    ResMed Common Stock

    [F1]
    2026-02-04$260.00/sh50$13,0009,691 total
Footnotes (1)
  • [F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025.
Signature
/s/ Michael J. Rider, Global General Counsel and Secretary|2026-02-05

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT